Anaerobic 4-hydroxyproline utilization: Discovery of a new glycyl radical enzyme in the human gut microbiome uncovers a widespread microbial metabolic activity. by Huang, Yolanda Y et al.
Lawrence Berkeley National Laboratory
Recent Work
Title
Anaerobic 4-hydroxyproline utilization: Discovery of a new glycyl radical enzyme in the 
human gut microbiome uncovers a widespread microbial metabolic activity.
Permalink
https://escholarship.org/uc/item/31q5t4v5
Journal
Gut microbes, 9(5)
ISSN
1949-0976
Authors
Huang, Yolanda Y
Martínez-Del Campo, Ana
Balskus, Emily P
Publication Date
2018
DOI
10.1080/19490976.2018.1435244
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
ADDENDUM
Anaerobic 4-hydroxyproline utilization: Discovery of a new glycyl radical enzyme
in the human gut microbiome uncovers a widespread microbial metabolic activity
Yolanda Y. Huang , Ana Martınez-del Campo#, and Emily P. Balskus
Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA
ARTICLE HISTORY
Received 21 December 2017
Accepted 23 January 2018
ABSTRACT
The discovery of enzymes responsible for previously unappreciated microbial metabolic pathways
furthers our understanding of host-microbe and microbe-microbe interactions. We recently
identified and characterized a new gut microbial glycyl radical enzyme (GRE) responsible for
anaerobic metabolism of trans-4-hydroxy-L-proline (Hyp). Hyp dehydratase (HypD) catalyzes the
removal of water from Hyp to generate D1-pyrroline-5-carboxylate (P5C). This enzyme is encoded in
the genomes of a diverse set of gut anaerobes and is prevalent and abundant in healthy human
stool metagenomes. Here, we discuss the roles HypD may play in different microbial metabolic
pathways as well as the potential implications of this activity for colonization resistance and
pathogenesis within the human gut. Finally, we present evidence of anaerobic Hyp metabolism in
sediments through enrichment culturing of Hyp-degrading bacteria, highlighting the wide
distribution of this pathway in anoxic environments beyond the human gut.
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Introduction
The trillions of microorganisms that live in and on the
human body play a central role in human physiology.1
Recent research focused on the inhabitants of the human
gastrointestinal tract (the human gut microbiota) has
highlighted the potential for this community to influence
host health and disease.2 While much progress has been
made in characterizing community compositions, we
know surprisingly little about the biochemical functions
of the gut microbiota and the mechanisms by which
microbes influence host biology.3 In order to understand
the metabolic potential of the gut microbiota and inform
mechanistic research, it is imperative that we link the
genes present in this habitat to functions. However, the
biological roles ofmostmicrobial genes remain unidenti-
fied, indicating a great need to investigate this uncharac-
terized genetic information.3,4
Discovery of a glycyl radical enzyme responsible
for anaerobic Hyp metabolism
We recently described a functional profiling pipeline
that can guide the discovery of novel enzymes in
microbiomes.5 We used this workflow to assess the
distribution of GREs in Human Microbiome Project
(HMP) metagenomes. Members of the GRE super-
family participate in anaerobic primary metabolism,
including DNA synthesis (class III ribonucleotide
reductase) and keto acid fermentation (pyruvate for-
mate-lyase and ketobutyrate formate-lyase).6,7 Fur-
thermore, GREs represent one of the most abundant
protein families in human stool metagenomes and
metaproteomes.8,9 A GRE must be posttranslationally
modified by a partner radical S-adenosylmethionine
(SAM) activating enzyme (AE), which installs a radi-
cal on the a-carbon of a conserved glycine residue
(Fig. 1A).7,10 The use of protein-based radicals enables
these enzymes to perform a diverse set of chemically
challenging transformations (Fig. 1A).6,7,10 Due to
their susceptibility to inactivation by molecular oxy-
gen, both GREs and AEs are only present in facultative
and obligate anaerobes.10,11
Our chemically guided functional profiling effort
identified HypD as a GRE of unknown function that
was both prevalent and highly abundant in the HMP
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stool metagenomes. To predict the biochemical func-
tion of HypD, we obtained insights from sequence
analyses, structure prediction, and analysis of its geno-
mic context. Sequence alignments of HypD with char-
acterized GREs and construction of a homology
model revealed an active site resembling those of GRE
dehydratases. Additionally, a gene annotated as P5C
reductase (P5CR) is colocalized with the hypD gene in
many Clostridial genomes. P5CR catalyzes the reduc-
tion of P5C to L-proline (Pro) in Pro biosynthesis. We
therefore hypothesized that this new GRE might cata-
lyze the removal of water from Hyp to generate P5C,
which could then be reduced to Pro by P5CR
(Fig. 1B). Using an in vitro coupled enzyme assay, we
validated this hypothesis experimentally. In addition,
HypD displays a strong preference for the biologically
relevant stereoisomer of 4-hydroxyproline, Hyp.
Together, these experiments confirmed the activity of
this prominent gut microbial GRE and revealed the
first anaerobic pathway for Hyp metabolism.
The discovery of HypD has allowed us to identify
microbial species capable of anaerobic Hyp metabo-
lism and to study the distribution of this activity
across various environments. In this addendum, we
discuss possible roles HypD may have in various
microbial metabolic pathways, assess the potential
biological relevance of anaerobic Hyp utilization
within the human gut microbiota, and present evi-
dence that this activity is widespread in additional
habitats. We also illustrate the importance of enzyme
discovery in microbiota research by highlighting how
expanding our knowledge of microbial metabolism
has helped to shed light on the roles of an underappre-
ciated, but abundant host-derived amino acid in the
gut microbiota.
Strategies for microbial Hyp metabolism
Our previous work examined Hyp metabolizing
enzymes, HypD, AE, and P5CR, from Clostridioides
difficile 70-100-2010 (formerly classified as Clostrid-
ium difficile). The presence of this pathway in the
order Clostridiales was notable given that anaerobic
metabolism of Hyp was first observed in Clostri-
diales.13 These organisms carry out Stickland fermen-
tation wherein pairs of amino acids are used as
electron donors and acceptors in energy metabolism.12
It was known as early as 1934 that Pro and Hyp can be
used as electron acceptors in such fermentations.12
Furthermore, it was shown that Hyp can induce the
expression of an enzyme responsible for Pro reduction
in C. difficile.13 In contrast to the characterized path-
way for Pro reduction (Fig. 2A), the enzymes and
downstream metabolites involved in Hyp fermenta-
tion had not been identified until our work.12
The discovery of HypD suggested that Stickland
fermentation of Hyp involves the generation
and reduction of Pro. Indeed, HypD is present in
species previously demonstrated to use Hyp and
Pro as electron acceptors (C. difficile, Clostridium
sporogenes).12,13 Notably, »65% of the Clostridiales
species that possess the prd operon, which is essential
for Pro reduction, also encode HypD.13,14 In these spe-
cies, the conserved proC gene (encoding P5CR) adja-
cent to hypD provides a strong indication that Hyp is
metabolized to Pro and used as an electron acceptor.
In Stickland fermentation, Pro is metabolized via a 2-
step pathway to 5-aminovalerate, which often accu-
mulates as an end product (Fig. 2A).14,15 To test
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Figure 1. (A) General mechanism of glycyl radical enzymes (GREs).
A partner radical S-adenosylmethionine (SAM) activating enzyme
(AE) first abstracts a hydrogen atom from the a-carbon of a con-
served active site glycine residue on the GRE to generate a car-
bon-centered radical. The glycine-centered radical is proposed to
abstract a hydrogen atom from an essential active site cysteine
residue to generate a thiyl radical intermediate that initiates reac-
tion with the substrate. Further reaction of the substrate-based
radical generates a product-based radical, which then abstracts a
hydrogen atom from the essential cysteine residue to regenerate
the thiyl radical. (B) Previously characterized activities of 4-
hydroxyproline dehydratase (HypD) and D1-pyrroline-5-carboxyl-
ate reductase (P5CR) from Clostridioides difficile 70-100-2010.
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whether HypD-encoding Clostridiales consume Hyp
via this pathway, we examined two strains encoding
both hypD and the prd operon (C. difficile 630Derm
and Terrisporobacter glycolicus DSM 1288). We con-
firmed that they generate 5-aminovalerate when
grown in the presence of Hyp (Fig. 3). In some species,
5-aminovalerate can be further metabolized for energy
production (Fig. 2A).16,17 Though enzymes involved
in these transformations have been purified and char-
acterized, their sequences have not been reported and
thus the distribution of this pathway in microbes
remains to be determined.
We next wondered whether HypD was important
for metabolic pathways beyond Stickland fermenta-
tion. A multigene BLAST18 search revealed that only a
small subset of HypD-encoding genomes has a neigh-
boring proC gene. This suggests that the majority of
HypD-containing species do not reduce Hyp to Pro.
In some organisms, including Oscillibacter valerici-
genes, a gene encoding a putative dehydrogenase is
located in close proximity to HypD, indicating that
P5C may be oxidized to L-glutamate.19 Additionally,
P5C can be converted into several other amino acids
(Fig. 4A).20–23 Interfacing HypD with these pathways
could allow microbes to access building blocks for
protein synthesis, substrates for fermentation, and
sources of carbon and nitrogen. Overall, the precise
role of Hyp and its downstream metabolites remain
unclear in most of the anaerobes that encode HypD
(Fig. 2B).
In addition to anaerobic Hyp metabolism mediated
by HypD, a different pathway allows aerobic bacteria
to use Hyp as a sole source of carbon and nitrogen
(Fig. 2D).24 The enzymes from this pathway have
been characterized in Pseudomonas and Sinorhi-
zobium.20,25 Aerobic Hyp metabolism involves
sequential oxidations of Hyp to generate a-ketogluta-
rate (a-KG) and ammonia, providing carbon and
nitrogen for anabolic pathways (Fig. 2D). cis-4-
Hydroxy-D-proline dehydrogenase carries out a key
step in this pathway and shares high sequence similar-
ity with hydrogen cyanide synthase, which is predicted
to use O2 as the terminal electron acceptor.
20,26 Given
its distribution and the potential requirement for O2,
we hypothesize that this metabolism occurs only in
aerobes. To assess the presence of this pathway in the
human microbiota, we performed TBLASTN27
searches of the HMP reference genomes (NCBI
A
N
H
OH
O
H2N OH
O
OH
O
OH
O
OH
O
L-Proline 5-Aminovaleric acid
+
++
Acetic acid Propionic acid
Valeric acid
NH3
NH3
B
C
D
N OH
O
N
H
HO
OH
O
Hyp
OH
O
O
HO
O
O
H
Pyruvic acidGlyoxylic acid
+
α-Ketoglutaric acid
HO OH
O
O O
+
NH3
P5C
Mammals Aerobic microbes
Anaerobic 
microbes
??
Stickland fermentation of L-proline
Figure 2. Characterized pathways for Hyp metabolism. (A) Pathway for Stickland fermentation using L-proline (Pro) as an electron accep-
tor. The product of Pro reduction, 5-aminovalerate, can be further oxidized and reduced by certain Clostridiales to generate short-chain
fatty acids and ammonia. (B) HypD provides an anaerobic route for Hyp metabolism. (C) In mammals, Hyp is oxidized to glyoxylate and
pyruvate in a multistep pathway. (D) An oxidative pathway for Hyp metabolism generates a-ketoglutarate (a-KG) and ammonia as sour-
ces of carbon and nitrogen.
GUT MICROBES 439
BioProject: PRJNA28331) using two characterized cis-
4-hydroxy-D-proline dehydrogenases20 as query. This
search identified hits mostly in organisms isolated
from
the skin and respiratory tract. Therefore, we can con-
clude that this alternative pathway likely does not con-
tribute significantly to Hyp consumption in the gut.
To summarize, there are two characterized path-
ways for Hyp metabolism in microbes (Fig. 2B, D).
Although we cannot rule out the possibility of addi-
tional, yet-to-be-discovered pathways, findings from
culture-based studies have clearly implicated these
two routes. The logic underlying these pathways is dis-
tinct, with the oxidative metabolism of Hyp providing
essential nutrients for aerobic bacteria, while the
anaerobic pathway uses Hyp as an electron sink to
regenerate NADC as part of Stickland fermentation in
Clostridiales, but likely has distinct roles in other
species.
HypD is widely distributed across microbial species
A particularly striking feature of HypD is its wide dis-
tribution in microbial genomes. Previous BLAST
searches revealed HypD in >850 genomes from the
NCBI database, with the majority of hits found in Fir-
micutes and Bacteroidetes.5 HypD is not just widely
distributed across bacterial phyla but is also present in
several archaeal genomes. Notably, we found HypD in
many common oral and gut species from genera Trep-
onema, Clostridium, Bacteroides, Parabacteroides, and
Enterococcus (Fig. 5), leading us to propose that HypD
is likely responsible for the anaerobic Hyp degradation
previously observed in human fecal and gingival sam-
ples.28,29 In addition to human commensals, HypD is
also encoded in several notable human pathogens
including C. difficile and Clostridium botulinum
(Fig. 5). To understand evolutionary relationships
between HypDs from different bacteria and archaea,
we constructed a phylogenetic tree using representa-
tive protein sequences from the UniProt database
(Fig. 5). HypD sequences mostly grouped according to
phylum with a few exceptions. Cetobacterium som-
erae, Collinsella sp., and Treponema species represent
three distinct phyla, but their HypD sequences all
claded with sequences from Firmicutes. Interestingly,
the hypD genes in these three organisms are colocal-
ized with an adjacent proC gene, sharing the genomic
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organization commonly found in Clostridiales. This
shared genomic context may indicate a recent hori-
zontal gene transfer event. Additionally, HypDs from
Odoribacter species form a distinct clade from the
HypDs found in other Bacteroidetes. Archaeal HypDs
formed their own clade and are closely related to
HypDs from thermophilic bacteria. Overall, the pres-
ence of HypD in eleven different phyla suggests that
Hyp utilization is an important metabolic function in
anaerobes.
Hyp is an abundant amino acid in the eukaryotic
world
The broad distribution of HypD suggests that Hyp is a
widely available substrate for microbial metabolism,
which is in agreement with the prevalence of Hyp bio-
synthesis. Hyp is an abundant non-proteinogenic
amino acid generated by prolyl 4-hydroxylase and
proline 4-hydroxylase enzymes. These mononuclear
non-heme iron and a-KG dependent dioxygenases are
found in all domains of life.30 Eukaryotes encode
prolyl 4-hydroxylases, which posttranslationally mod-
ify Pro residues in proteins and peptides.30 In mam-
mals, Hyp is almost exclusively found in collagen,
which is the most abundant protein in the human
body.30 Hyp formation is also critical for the function
of additional structural and regulatory proteins,
including elastin and hypoxia inducible factor.30 Over-
all, Hyp is estimated to make up »4% of the amino
acid pool in the human proteome, making it more
abundant than several proteinogenic amino acids.30 In
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addition to animals, plants and algae also produce
proteins enriched in Hyp that are important for cell
wall rigidity, growth, and signaling.30,31 Indeed, Hyp-
rich glycoproteins (HRGPs) are a major component of
residues serving as sites for O-glycosylation.
In contrast to its prevalence in eukaryotes, Hyp bio-
synthesis is uncommon in bacteria and archaea. Most
Hyp-generating species use proline 4-hydroxylases to
hydroxylate free Pro.30 Free Hyp is synthesized by hal-
ophiles and acts as an osmolyte under high salt con-
centrations.33 Hyp is also generated for use as a
building block in the biosynthesis of non-ribosomal
peptides, including actinomycin and etamycin.34,35
There are also two reported examples of bacterial
prolyl 4-hydroxylases that form Hyp through post-
translational modification of peptidyl Pro.36,37 Overall,
it appears that eukaryotes are the primary source of
Hyp with bacteria contributing to a much lesser
extent.
Sources of Hyp and its metabolism by the human
host
The prevalence of HypD in the human gut microbiota
raises the fascinating question of how these organisms
obtain Hyp. Because Hyp is highly abundant in both
mammalian and plant proteins, a wide variety of die-
tary substrates contain this amino acid (Fig. 4B). In
meat products, Hyp content correlates with the
amount of connective tissue and can be detected at up
to 1% in weight.38,39 Hyp is also enriched in dietary
fibers that contain plant cell wall polysaccharides as a
major component. For example, Hyp makes up over
4% of the protein content in dietary fibers extracted
from grape pomace.40 Arabinogalactan proteins, a
class of HRGPs, are also a major component in gum
arabic, which is used as a thickening and stabilizing
agent in the food industry and is found in products
like candies, gum, and beverages.41 In addition to die-
tary sources, it is estimated that endogenous collagen
turnover in humans releases »300 mg of Hyp daily.42
Overall, both diet and endogenous collagen are candi-
date sources of Hyp for microbial metabolism in the
human body (Fig. 4B).
The availability of Hyp to the gut microbiota may
also be influenced by host pathways for processing
this amino acid. A metabolomics study in humans
identified Hyp as a top plasma biomarker for distin-
guishing omnivores from vegans due to its higher
abundance in omnivores.43 This finding supports the
proposal that diet is a significant source of Hyp and is
potentially in agreement with the higher Hyp content
of meat as compared to plant material. This result
may also suggest that dietary changes affect the degree
to which gut microbes and/or the host metabolize
Hyp. In humans, 80–90% of free Hyp is efficiently
metabolized to glyoxylate and pyruvate in the kidneys
and liver (Fig. 2C).21,42 Glyoxylate produced from
host Hyp metabolism can be oxidized to oxalate, the
accumulation of which can lead to kidney stone for-
mation.44 Up to 95% of Hyp excreted in the urine is
incorporated into peptides, with Pro-Hyp as the major
species.42 Interestingly, this peptide is not efficiently
hydrolyzed by host peptidases.45,46
In addition to Hyp-containing foods, collagen itself
is often recommended as a dietary supplement and
there is evidence that collagen-derived peptides have
beneficial effects on host cells, including antioxidant,
anticancer, and proliferative activities.46 Collagen-
derived peptides have been detected in plasma after
ingestion of collagen.46 Contribution of the gut micro-
biota to hydrolysis of both host and dietary collagen
and collagen-derived peptides has not been studied in
detail and may have a significant impact on the avail-
ability of these bioactive peptides for the host. In addi-
tion, we propose that the gut microbiota could
complement host protein metabolism by hydrolyzing
recalcitrant short peptides to release free amino acids
for further use by both microbes and host. This pro-
cess would parallel the roles of gut microbes in metab-
olizing indigestible polysaccharides.
Biological implications of HypD activity in the
human gut microbiota
The conditions under which Hyp metabolism occurs
in the human gut and the effects of this microbial met-
abolic activity on host biology are not clear. As Hyp is
rarely included in amino acid measurements, Hyp
concentrations within the gastrointestinal tract are
largely unknown, with one study detecting free Hyp as
the most abundant amino acid in the large intestine of
one human subject.47 Likewise, Hyp metabolism
by gut microbes has not been studied in detail.
However, metabolomics experiments in animal
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models provide evidence that gut microbes can use
this amino acid.48-50 Specifically, free Hyp and Hyp-
containing peptides (Pro-Hyp, Gly-Pro-Hyp) were
detected at higher levels in the urine and feces of
studies strongly suggest that a significant amount of
free Hyp and Hyp-containing peptides reaches the gut
and that the gut microbiota plays a major role in Hyp
metabolism.
Given the prominence of HypD in the healthy
human gut microbiome, we propose that Hyp utiliza-
tion plays a vital role in this microbial community.
This primary metabolic pathway may influence many
aspects of the gut microbiota and its interactions with
the host. Specifically, Hyp metabolism may play a role
in shaping microbiota composition by enabling organ-
isms to access nutrients an energy source. Consump-
tion of Hyp by gut commensals may deplete levels of
this amino acid and potentially contribute to coloniza-
tion resistance against HypD-encoding pathogens.
Hyp metabolism may also be important in diseases
that involve pathogen infiltration of host tissues and
collagen degradation. Finally, the end products of Hyp
metabolism may serve as signals to host cells. Here,
we explore these potential roles of Hyp metabolism
within the human body.
Increased Hyp uptake from the diet or increased
turnover of endogenous collagen may promote the
growth and expansion of gut microbes possessing
HypD. Because the product of HypD, P5C, can be
metabolized in various ways, we expect the fitness
advantages conferred upon HypD-encoding species to
depend on the overall nutrient landscape of the gut
environment. For example, Stickland fermentation of
Hyp is an energy-yielding process and could provide a
significant growth advantage to Clostridiales over
other HypD-encoding species when alternative elec-
tron acceptors are scarce.
In addition to Clostridiales, HypD is present in many
common human gut Bacteroides and Parabacteroides
species, including Bacteroides vulgatus and Parabacter-
oides distasonis (Fig. 5). Bacteroidetes are known for
their ability to catabolize complex dietary and host-
derived polysaccharides, which are often covalently
linked to protein residues.51 The prevalence of HypD in
gut Bacteroidetes suggests that HRGPs may provide
both carbohydrates and amino acids to gut microbes,
and HypD-encoding species may possess proteases and
hydrolases to access Hyp and other amino acids from
these large glycoprotein substrates. The identification of
gut bacterial enzymes that release free Hyp from either
dietary plant glycoproteins or collagen presents an
important challenge for future investigations.
In addition to supporting the growth of commensal
microbes, Hyp metabolism may be important for colo-
nization of opportunistic pathogens and toxin produc-
tion. For example, C. difficile can utilize both Hyp and
Pro as electron acceptors.13 Although the regulation of
toxin production in C. difficile is not well understood,
fermentation of Pro and other amino acids are
thought to indirectly influence this process by
modulating NADH/NADC ratios in the cell.52 Since
metabolism of Hyp to Pro generates NADC, this
transformation may also affect virulence in C. difficile.
Metabolomics and transcriptomics experiments
in a mouse model for C. difficile infection have con-
cluded that Stickland pathways are critical for host
colonization.53,54 Of particular interest, Pro reduction
was highly ranked among pathways important for C.
difficile colonization.53 Hyp and Pro were also effi-
ciently metabolized by C. difficile upon infection in
antibiotic-treated mice.53 Many studies have indicated
that a diverse gut microbiota can confer colonization
resistance against C. difficile.55 One mechanism by
which this may occur is through restricting the meta-
bolic niches available for the pathogen.53 We propose
that HypD-encoding commensals in the healthy
human gut may consume Hyp, reducing its availabil-
ity to C. difficile. Disruption of the gut microbiota
with antibiotics could reduce Hyp metabolism,
increasing the concentrations of this key substrate.
This hypothesis can be tested by studying colonization
resistance in mice using a defined microbiota contain-
ing or lacking HypD. Understanding the role of Hyp
utilization in C. difficile could have implications for
efforts to develop defined microbial consortia as thera-
peutics in patients with recurrent C. difficile infection.
It is likely that gut microbial acquisition of Hyp from
host collagen could also affect host biology. Collagen is
the principle source of Hyp in the human body and a
major component of the extracellular matrix in connec-
tive tissues, including the basement membrane underly-
ing the gut epithelium.56 In the context of various
diseases, the host inflammatory response and certain
bacterial pathogens can degrade collagen, resulting in a
breach of this barrier.57 The resulting release of peptides
and amino acids could increase nutrient availability for
microbes and potentially alter the composition and
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functions of the microbiota. Microbial collagenases are
not well understood mechanistically, but have been
linked to diseases such as periodontitis.58 Identification
and characterization of collagenases from gut microbes
lagen degradation in diseases involving impaired gut
barrier function, including inflammatory bowel disease.
The end products of anaerobic Hyp metabolism
may also interact with host cells. Notably, 5-amino-
valerate, a product of Stickland fermentations
involving Hyp and Pro, has been detected in the
cecum and feces of mice, suggesting that Pro
reduction is an active pathway in the gut micro-
biota.48,50,59 Intriguingly, 5-aminovalerate is a
chemical analog of g-aminobutyric acid (GABA)
and a weak antagonist of GABAB receptor.
60
These inhibitory receptors are activated upon
GABA binding. In animals, GABAB receptors are
expressed in the enteric nervous system and play a
role in regulating gastrointestinal motility.61
They are also expressed in immune cells, and
recent studies have linked GABAergic signaling to
inflammation.61 The prominence of Hyp metabo-
lism in the gut raises the intriguing possibility that
HypD-mediated Stickland fermentation may con-
tribute significantly to 5-aminovalerate production,
potentially altering gut motor and immune
functions.
Overall, the discovery of HypD has not only pro-
vided a more comprehensive understanding of a pre-
viously observed microbial metabolic activity, but also
revealed its wide distribution in sequenced microbial
genomes and potential to influence host health and
disease. The many exciting research directions
highlighted throughout this section illustrate the
importance of incorporating enzyme discovery efforts
into microbiota research. We anticipate that future
investigations of these hypotheses will reveal a signifi-
cant contribution of anaerobic Hyp metabolism in
shaping gut microbiota composition and influencing
host physiological and pathological states.
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Figure 6. (A) Workflow for enrichment culturing to obtain Hyp-
degrading environmental microbes. Hyp-containing supplements
were added to certain samples before inoculation into the Hyp
enrichment medium. Turbidity and Hyp degradation were
observed in all initial cultures before passaging into fresh
medium. All cultures were incubated anaerobically at 30C in
sealed vessels. (B) High Performance Liquid Chromatography-
Refractive Index Detector (HPLC-RID) traces for the four enrich-
ments further passaged for sequencing to show Hyp degradation.
Samples were derivatized with nitrosonium, generated from
potassium nitrite and hydrogen chloride, to obtain N-nitroso
derivatives of Pro and Hyp for separation on an Aminex HPX-87P
column.69 The previously reported method was modified to
include an isocratic elution at 60C for 40 minutes.
Table 1. All samples were collected at various locations around
Woods Hole, MA, USA.
Sampling site Sample type Supplement
Passaged and
sequenced
cultures
Trunk River Sediment Beef extract TR Beef
Peptone TR Peptone
Hyp TR Hyp
Cedar Swamp Mud Ced. Swamp
Little Sippwissett Salt Marsh Microbial mat
School Street Marsh Mud
Samples were supplemented with Hyp or various Hyp-containing sources and
incubated at room temperature before inoculation into enrichment medium.
Table 2. Hyp enrichment medium composition.
Component Concentration
NaCl 100 g/L
MgCl2¢6H2O 40 g/L
CaCl2¢2H2O 10 g/L
KCl 50 g/L
NH4Cl 10 mM
KH2PO4 4 g/L
K2HPO4 12.7 g/L
MOPS buffer, pH 7.2 10 mM
Sodium formate 40 mM
Sodium acetate 1 mM
Hyp 20 mM
Thiosulfate 0.25 mM
Sodium sulfide 0.25 mM
Sodium 2-bromoethanesulfonate 10 mM
ATCC trace mineral 1%
ATCC vitamin solution 1%
Resazurin 0.0001%
added after passaging 2–3 times.
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Beyond the human gut: Exploring anaerobic Hyp
metabolism in other environments
In addition to human-associated microbes, we located
HypD in the genomes of many environmental isolates
mostly from the phyla Firmicutes, Proteobacteria, and
Synergistetes (Fig. 5). The wide distribution of anaero-
bic Hyp utilization in these environmental strains sug-
gests that this metabolic activity is important in a
diverse range of microbial habitats.
Table 3. Primers and annealing temperatures used in this study.
Target
gene
Primer
name Primer sequence (5’ to 3’)
Amplicon
size
(bp)
Annealing
temperature
(C)
hypD HypD
F149aa
hypD HypD
R261aa
TGNACRAACCARTACATYTG 357 50
Firmicutes
Bacteroidetes
Proteobacteria
Synergistetes
Elusimicrobia
Candidatus Cloacimonetes
Ced. Swamp   TR Hyp   TR Beef   TR PeptoneEnrichment cultures:
100
100
100
70
100
100
95
84
100
100
82
100
100
53
100
100
98
100
98
100
85
91
89
86
71
100
100
68
80
87
53
0.050 HypD– HypD+
  Sedimentibacter sp. B4
 G3 (Sedimentibacter)
 C5 (Sedimentibacter)
 D5 (Sedimentibacter)
 C6 (Sedimentibacter)
 D1 (Sedimentibacter)
 C8 (Sedimentibacter)
 D12 (Sedimentibacter)
 C7 (Sedimentibacter)
 Acetobacterium woodii DSM 1030
 Clostridioides difficile 630
 E2 (Clostridium XI)
 E4 (Clostridium XI)
 A4 (Clostridium XI)
 Lachnospiraceae bacterium 6 1 37FAA
 H1 (Clostridium XlVa)
 Oscillibacter valericigenes Sjm18-20
 A3 (Clostridium IV)
 D2 (Clostridium IV)
 E10 (Clostridium IV)
 Bacteroides vulgatus ATCC 8482
 A2 (unclassified Bacteroidales)
 E1 (unclassified Rikenellaceae)
 Desulfovibrio desulfuricans DSM 7057
 C2 (Desulfovibrio)
 G1 (Desulfovibrio)
 E3 (Desulfovibrio)
 Synergistes jonesii 78-1
 D4 (unclassified Synergistaceae)
 D3 (Aminiphilus)
 C9 (unclassified Synergistaceae)
 Endomicrobium proavitum Rsa215
 D7 (Candidatus Endomicrobium)
 Candidatus Cloacamonas acidaminovorans 
 B3  (Candidatus Cloacamonas) 
 Treponema lecithinolyticum ATCC 700332
 Treponema maltophilum ATCC 51939
 A10 (Acetobacterium)
 B5 (Acetobacterium)
 D9 ( Acetobacterium)
Figure 7. 16S rDNA phylogenetic tree of enrichment culture isolates and reference species. 16S rRNA genes were amplified using pri-
mers 8F and 1510R (Table 3) and sequenced from a pCR4-TOPO clone library (Invitrogen). Chimeric, low-quality, and redundant sequen-
ces were removed. 28 sequences from enrichment cultures and 12 reference sequences were aligned with MUSCLE.70 The alignment
was manually trimmed to yield a final length of 1371 bp and a maximum likelihood tree was constructed in MEGA767 using the
Tamura–Nei method of substitution.71 Bootstrap values from 50 to 100% are displayed. The highest similarity score calculated by RDP
SeqMatch was used to assign the lowest classification level for each enrichment isolate.72 The full-length sequences obtained for this
analysis have been deposited in GenBank (accession: MG367094-MG367121).
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To gain insights into Hyp consumption in the envi-
ronment, we examined the presence of this metabolic
capability in hypoxic sediments (Fig. 6A). Sediment
samples were collected from various wetlands around
Woods Hole, MA, USA. A subset of these samples
was first incubated in the presence of Hyp or Hyp-
containing supplements before inoculation into a
defined medium containing Hyp as an electron accep-
tor and carbon source (Tables 1–2). Consumption of
Hyp was confirmed in all enrichment cultures via
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Figure 8. (A) A degenerate primer pair amplified an expected 357 bp product from genomic DNA of HypD-encoding isolates. No ampli-
fication product was observed using the genomic DNA of species lacking HypD. (B) Amplification of hypD from 100 ng of DNA from
enrichment cultures. Amplicons were sequenced from a clone library generated using TOPO TA cloning kit (Invitrogen). 24 clones from
each culture were sequenced by Beckman Coulter Genomics. High quality sequences that are non-redundant within each culture have
been deposited on GenBank (accession: MG367122-MG367168). (C) Non-redundant translated amino acid sequences from each enrich-
ment culture were aligned using Clustal Omega73 along with the biochemically characterized HypD from C. difficile 70-100-2010 (Uni-
Prot ID: A0A031WDE4). The two HypD putative active site residues encoded within this amplicon are present in all enrichment
sequences and are indicated by asterisks. “Residue numbering is based on HypD sequence from C. difficile 70-100-2010.”
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High Performance Liquid Chromatography-Refractive
Index Detector (HPLC-RID) (Fig. 6B). Four enrich-
ment cultures were selected for further passaging
(Table 1). To identify the bacteria present in these
using universal primers (Table 3). Phylogenetic anal-
ysis of these 16S rDNA sequences revealed that the
enrichments were dominated by Firmicutes (Fig. 7).
Very few 16S rDNA sequences yielded identical
matches in the NCBI non-redundant nucleotide data-
base,63 indicating that most of these species have not
been cultivated nor sequenced. In particular, two
sequences are part of recently identified phyla (Candi-
datus Cloacimonete and Elusimicrobia) that have no
or very few cultivated representatives.64,65 Overall,
most of the species present in the Hyp enrichments
are closely related to sequenced organisms that encode
HypD, indicating they likely also possess this enzyme
(Fig. 7).
We sought to directly identify hypD genes in the
enrichment cultures by designing degenerate pri-
mers to target conserved regions present in all
HypD sequences from the UniProt database
(Table 3). Amplification conditions were optimized
using genomic DNA from Clostridiales and Bacter-
oidales (Table 3, Fig. 8A). A fragment of the
expected size for the hypD amplicon was amplified
from DNA extracted from all passaged enrichment
cultures (Fig. 8B). These amplicon sequences do
not have highly identical hits (<80% ID) in the
NCBI nucleotide database, further demonstrating
that Hyp-metabolizing species in these enrichments
have not been sequenced. To confirm that the
amplicons do represent hypD fragments, BLASTP27
was performed using unique translated amino acid
sequences of HypD sequences amplified from each
enrichment against all GREs from our previously
constructed sequence similarity network.5 All top
50 hits mapped back to nodes within the HypD
cluster of the sequence similarity network, with
most of the enrichment sequences resembling
HypD sequences from Firmicutes. This result is
consistent with the high abundance of Firmicutes
in these samples as determined from the 16S
rDNA analysis. The two putative HypD active site
residues (C. difficile HypD: F152, H160)5 encoded
within the amplified region are conserved in all
enrichment amplicons (Fig. 8C). Together, these
results strongly support the presence of HypD in
the four sediment enrichment cultures and suggest
that this enzyme was responsible for the observed
Hyp consumption. Lastly, the discovery of new,
partial HypD sequences points to a much broader
distribution of this activity across microbial diver-
sity than is currently captured in sequenced
genomes.
Conclusion
The discovery of HypD revealed a prominent meta-
bolic pathway in the human gut microbiota that is
responsible for anaerobic Hyp metabolism. Hyp is
converted to P5C, which can then be processed in dif-
ferent ways to support microbial growth and survival.
Given the strong evidence for Hyp utilization in the
human gut microbiota and the wide distribution of
HypD in strains from this habitat, we hypothesize that
this activity has important roles in shaping gut micro-
biota composition and could affect host health and
disease. Identification of the hypD gene will now
enable the use of bacterial genetics and defined micro-
bial consortia to elucidate the biological roles of this
pathway in animal models. Further efforts to detect
and quantify hypD in patient metagenomes and meta-
transcriptomes may reveal unanticipated correlations
between this pathway and additional host phenotypes.
Overall, the elucidation of a new enzymatic activity in
the human gut microbiota has both expanded our
knowledge of gut microbial metabolism and illumi-
nated exciting directions for future research.
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